OpenOnco
UA EN

Onco Wiki / Actionability

CCND1 (cyclin D1) overexpression in MM strongly correlates with t(11;14) and BCL2 depende...

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

IDBMA-CCND1-IHC-MM
TypeActionability
Statusreviewed 2026-04-27 | pending_clinical_signoff | actionability review required
DiseasesDIS-MM
SourcesSRC-NCCN-MM-2025

Actionability Facts

BiomarkerBIO-CCND1-IHC
VariantCCND1 expression / cyclin D1 IHC (often surrogate for t(11;14))
DiseaseDIS-MM
ESCAT tierIIA
Recommended combinationsvenetoclax + dexamethasone (off-label, t(11;14)-surrogate)
Evidence summaryCCND1 (cyclin D1) overexpression in MM strongly correlates with t(11;14) and BCL2 dependence — predicts venetoclax response. Used as surrogate when FISH unavailable.

Notes

ESCAT IIA. Use FISH t(11;14) when available; CCND1 IHC as surrogate.

Used By

No reverse references found in the YAML corpus.